Intent to Sole Source - ORTHO Vision Equipment

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NATIONAL INSTITUTES OF HEALTH

Contract Value

Not provided

Codes & Classification
Solicitation Number

NOI-CC-OLAO-26-006399

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6640

Additional Details
Set Aside

NONE

Place of Performance

Bethesda, Maryland, UNITED STATES

SourceSAM
Documents3
The National Institutes of Health (NIH), Clinical Center (NIH-CC), located in Bethesda, Maryland, has issued a Special Notice indicating its intent to negotiate a sole source procurement with QuidelOrtho Sales Company, LLC. This notice, identified by Procurement Identifier NOI-CC-OLAO-26-006399, is not a request for proposal but rather a public declaration of the agency’s plan to acquire specific equipment under an other than full and open competition basis, as authorized by 41 U.S.C. 253(c)(1) and implemented by FAR 6.302-1. The statutory justification is that only one responsible source is capable of meeting the agency’s requirements. The procurement concerns the acquisition of ORTHO Vision Equipment, a critical instrument manufactured by Quidel-Ortho Clinical Diagnostics, Inc. This technology is integral to the Department of Transfusion Medicine (DTM) at NIH-CC, where it is used for pretransfusion testing, including blood grouping and antibody detection. The ORTHO Vision system is essential for determining red blood cell compatibility prior to transfusion, directly supporting patient safety by minimizing wait times and reducing the potential for human error through its fully automated workflow. The intended outcome of this procurement is to maintain and enhance the reliability and safety of transfusion services at the NIH Clinical Center. Key requirements for this acquisition include the provision of equipment that is fully compatible with existing Quidel-Ortho Clinical Diagnostics technology, ensuring seamless integration into current laboratory operations. The expected deliverables are the ORTHO Vision instruments themselves, which must support automated, high-throughput pretransfusion testing and align with the Clinical Center’s stringent standards for accuracy and safety. This procurement falls under NAICS Code 334516 (Analytical Laboratory Instrument Manufacturing) and Product Service Code 6640. There are no set-aside requirements associated with this notice; it is not restricted to small businesses or any other socioeconomic category. The place of performance is Bethesda, Maryland, within the United States. Interested parties who believe they can meet the requirements outlined in this notice are invited to submit a capability statement by email to [email protected], referencing NOI-CC-OLAO-26-006399 in the subject line. All responses received by 12:00 PM Eastern Standard Time on May 29, 2026, will be considered by the Government. However, the final determination to proceed with a non-competitive action rests solely with the Government. The contracting entity for this procurement is the National Institutes of Health, an agency within the Department of Health and Human Services. The notice remains active and can be accessed via the official SAM.gov portal at https://sam.gov/opp/445c0b3d3737406088151a180f7af16a/view, where additional attachments may be available for review. Contractors evaluating this opportunity should note that the requirement is highly specialized, with a clear preference for equipment that is fully compatible with existing Quidel-Ortho systems. The procurement is driven by the need for continuity, reliability, and safety in critical clinical laboratory operations, and any alternative solutions must demonstrably meet or exceed the current system’s capabilities.